[Table/Fig-4]:
Blood investigations in relation to Renal failure status of patients studied.
| Variables | Renal failure (RF) | All patients (n=101) |
p-value | |
|---|---|---|---|---|
| Absent (n=85) |
Present (n=16) |
|||
| Urea (mg%) | 28.98±8.91 | 57.64±9.69 | 33.52±13.83 | <0.001** |
| Creatinine mg% (Day1) | 0.87±0.21 | 1.59±0.29 | 0.99±0.34 | <0.001** |
| Creatinine mg% (Day 14) | 0.64±0.18 | 0.93±0.11 | 0.69±0.20 | <0.001** |
| Haematocrit (%) | 44.64±6.18 | 47.58±6.62 | 45.10±6.31 | 0.088+ |
| Hemoglobin (g/dl) | 14.06±2.10 | 15.34±2.32 | 14.26±2.17 | 0.030* |
| Platelets (cells/cmm) | 77832.94±68221.56 | 27912.50±23870.68 | 69924.75±65806.89 | 0.005** |
| Creatine kinase (U/L) | 127.59±210.53 | 99.38±112.46 | 123.12±198.08 | 0.604 |
| Total Bilirubin (mg/dl) | 1.10±1.02 | 1.82±2.49 | 1.22±1.37 | 0.053+ |
| Direct Bilirubin (mg/dl) | 0.45±0.58 | 0.74±0.79 | 0.49±0.63 | 0.086+ |
| Albumin (g/l) | 3.40±0.82 | 3.28±0.54 | 3.38±0.78 | 0.590 |
| AST (U/l) | 207.73±560.37 | 700.75±2170.00 | 285.83±1001.42 | 0.071+ |
| ALT (U/l) | 101.75±164.5 | 272.38±696.27 | 128.78±315.23 | 0.046 |
| ALP (U/l) | 103.27±61.75 | 88.69±37.28 | 100.96±58.65 | 0.364 |
| Lactate Dehydrogenase (U/L) | 134.86±409.94 | 143.06±116.73 | 136.16±378.44 | 0.937 |
| Sodium (mmol/L) | 135.90±15.13 | 135.37±3.13 | 135.82±13.92 | 0.889 |
| Potassium (mmol/L) | 10.04±41.22 | 4.22±0.51 | 9.12±37.84 | 0.575 |
| Cholesterol (mg/dl) | 145.57±34.00 | 126.50±50.62 | 142.55±37.47 | 0.062+ |
| Total Leucocyte count (cells/cmm) | 9943.59±17565.66 | 18637.50±26711.89 | 11320.84±19400.78 | 0.100 |
| Prothrombin time | 12.22±2.03 | 13.22±2.76 | 12.38±2.18 | 0.090+ |
| Activated partial thromboplastin time (seconds) | 31.82±9.08 | 29.83±7.66 | 31.50±8.87 | 0.414 |
Student t-test